Author:
Forker R.,Escher M.,Stange E. F.
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. De Vries HS, de Heij T et al (2012) Infliximab exerts no direct Hepatotoxic effect on hepG2 cells in vitro. Dig Dis Sci 57:1604–1608
2. Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayasi PH, Kleiner DE, Serrano J, Rochon J, Fontana RJ, Bonacini M (2013) Liver injury from tumor necrosis factor-α-antagonists: Analysis of thirty-four cases. Clin Gastroenterol Hepatol 11:558–564
3. Kinnunen U, Färkkilä M, Mäkisalo H (2012) A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (Infliximab), and subsequent liver necrosis. J Crohns Colitis 6:724–727
4. Lee WM, Hynan LS, Rossaro L et al (2009) Intravenous N‑acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 137:846–864
5. Mancini S, Amorotti E et al (2010) Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med 5:193–200
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献